𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lack of Interactions between Breast Cancer Resistance Protein (BCRP/ABCG2) and Selected Antiepileptic Agents

✍ Scribed by Lukas Cerveny; Petr Pavek; Jana Malakova; Frantisek Staud; Zdenek Fendrich

Book ID
109108849
Publisher
Wiley (Blackwell Publishing)
Year
2006
Tongue
English
Weight
292 KB
Volume
47
Category
Article
ISSN
0013-9580

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interactions of azole antifungal agents
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP)
✍ Anshul Gupta; Jashvant D. Unadkat; Qingcheng Mao πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 169 KB

Breast cancer resistance protein (BCRP) is an efflux transporter that plays an important role in drug disposition. The goal of this study was to investigate the interactions of azole antifungal agents, ketoconazole, itraconazole, fluconazole, and voriconazole, with BCRP. First, the effect of the azo

Reversal of breast cancer resistance pro
Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic
✍ Ken Shiozawa; Mikio Oka; Hiroshi Soda; Megumi Yoshikawa; Yoji Ikegami; Junji Tsu πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 165 KB πŸ‘ 1 views

## Abstract Breast cancer resistance protein (BCRP/ABCG2) of an ATP‐binding cassette half‐transporter confers resistance against mitoxantrone and camptothecin derivatives of topotecan and irinotecan. Novobiocin, a coumermycin antibiotic, is known to enhance anticancer drug sensitivity of cancer cel